Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intestinal inflammatory diseases].

Christian Felley1, Christian Mottet, Jurg Hess

  • 1Service de gastro-entérologie et hépatologie, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|March 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial mapping of human colonic niches reveals rapid, mucus-specific microbiota disruption after bowel cleansing.

Gut microbes·2026
Same author

Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease.

Inflammatory bowel diseases·2025
Same author

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Clinics and research in hepatology and gastroenterology·2025
Same author

International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for Improvements.

United European gastroenterology journal·2025
Same author

Early mechanical failure of posterior lumbar fusion: Literature review based on an illustrative case.

Neuro-Chirurgie·2025
Same author

Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co-Design Approach With General Practitioners and Patients.

Basic & clinical pharmacology & toxicology·2025
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Last year saw no major breakthroughs in inflammatory bowel disease treatments. However, new anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapies are expected soon, offering future hope.

Area of Science:

  • Gastroenterology and Immunology
  • Pharmacology

Context:

  • Inflammatory bowel diseases (IBD) represent a group of chronic gastrointestinal disorders.
  • Current therapeutic options for IBD have limitations.

Purpose:

  • To review the therapeutic landscape of inflammatory bowel diseases over the past year.
  • To highlight emerging treatment modalities.

Summary:

  • No significant new therapeutic advances were reported for inflammatory bowel diseases (IBD) in the last year.
  • Existing treatments, such as infliximab, remain important.
  • New biologic agents targeting tumor necrosis factor-alpha (anti-TNF-alpha) are anticipated to become available.

Impact:

  • The upcoming availability of new anti-TNF-alpha agents may expand treatment options for IBD patients.

Related Experiment Videos

  • Further research is needed to evaluate the efficacy and safety of these novel therapies.